Independent Review Committee

in page functions

Gavi has established an Independent Review Committee for the review of new proposals

To support an independent and systematic process of reviewing new proposals, Gavi has established an Independent Review Committee (IRC).

Key characteristics

Since its inception, the structure and composition of the Gavi IRC have been considered effective due to key characteristics:

  • the committee relies upon a wide range of experts in public health, epidemiology, development, finance and economics;
  • the committee is based on a system of peer review; and
  • the committee is independent.

The Gavi Board

The IRC is directly accountable to the Gavi Board and communicates its recommendations to the Gavi Board. The Gavi Board makes the ultimate decision on whether to approve the funding of new country grants. The Gavi Board also has the responsibility for communicating its decision to countries, via the Gavi Secretariat.

Keeping in mind the realistic planning timelines, countries should target a submission deadline that meets their implementation timelines.

 

Round 1  

Round 2  

Round 3  

Submission cut-off dates

22 January 2019

1 May 2019

4 September 2019

Review dates (indicative)

11-22 March 2019

1–12 July 2019

28 Oct - 8 Nov 2019

The Independent Review Committee reviews new proposals and makes recommendations to the Gavi Board

The mandate of the new proposals IRC is to review each application for all types of new support, to enable a more holistic view of the broad portfolio of support Gavi provides to countries, rather than looking at each new application in isolation from the others, and to make recommendations to the Gavi Board.

This review should consider the information available to countries within current guidelines and application forms and ensure that any new proposal contributes to achieving:

  • the Gavi mission - ‘To save children’s lives and protect people’s health by increasing access to immunisation in poor countries’;
  • the Gavi's strategic goals; and
  • the eligibility criteria as per Gavi guidelines for new proposals of support.

Members of the Independent Review Committee consist of specialists from a broad range of expertise

IRC members generally serve a term of three years. This term may be renewed for another period of up to 3 years. Upon reaching the second term limit IRC members will not be eligible to serve on the IRC for at least 1 year. During their term IRC members may be called upon to serve on the IRC for review of country plans or requests for extensions for which he or she has specific relevant skills.

Click here to view Terms of Reference for the Gavi Independent Review Committee  

Range of expertise

The increasing complexity of new proposals and the subsequent grant monitoring requires an IRC with a broad range of expertise in areas such as:

  • Routine immunisation programmes, especially at country level;
  • Management of campaigns;
  • Delivery of health services including child and adolescent health;
  • Health systems strengthening and management;
  • Epidemiology and disease control;
  • Cold chain and logistics;
  • Financial and budget analysis; and
  • Gender and equity.

The IRC should also consist of technical experts knowledgeable on the developing country context and relevant issues, including in a variety of fields related to immunisation and health systems, and who have practical experience working in or with developing country governments, civil society, and other partners in those contexts. In addition, the IRC should be geographically diverse, with a male and female representation consistent with Gavi’s Gender Policy and Guidelines on the Gavi Board Gender Balance.

Each IRC member is asked to sign a confidentiality and conflict of interest statement and will not come from Vaccine Alliance partner agencies, and have not taken part in technical assistance to or pre-review processes of country applications.

List of IRC pool members

Click here to view the biographies of the IRC members  

 NameAreas of expertise
1Emmanuel Addo-YoboChild health, clinical paediatrics, surveillance for rotavirus and congenital rubella syndrome
2Salah Al AwaidyVaccine-preventable diseases programming, epidemiology, public health, immunisation, M&E, AEFI, campaigns
3Rafah Salam AzizMNCH programme management, immunisation
4Brent Burkholder Epidemiology, vaccine programmes and disease control, outbreak investigations
5Diego BuriotPublic health interventions, communicable diseases, fragile and crisis settings
6Pierre BwaleHealth care delivery, campaigns, emergencies, programmes for hard-to-reach communities
7Lisa CairnsImmunisation policy, epidemiology, M&R control, national immunisation programme reviews
8Aleksandra CaricImmunisation, vaccine safety and regulation, programme management and administration
9Sadia ChowdhuryReproductive Health, HSS, child health services, programme delivery, M&E of health programmes
10John ClementsRoutine immunisation services in developing countries
11Natasha CrowcroftEpidemiology, HSS, HPV, measles, outbreak control, training and capacity building
12Dora CurryCSOs, data systems at community and primary care level, data utilization for programme improvement
13Celestino CostaCold chain, immunisation, HSS, emergency responses, primary health care
14John Crump Infectious diseases, epidemiology, outbreak responses, typhoid
15Henrique D’AlvaCold chain, EPI logistics
16Kevin De CockGlobal public health, HIV, emergency & outbreak response, HSS
17Modibo DickoSupply chain management, introducing innovative technologies, management systems and practices in health supply systems
18Marta FelettoGender equality, M&E, immunisation programme, HPV
19Djordie GikicHSS, proposal development, immunisation systems evaluation, service delivery, health policies
20Melita GordonGastroenterology, disease surveillance, typhoid, vaccine trials
21John GrundyHealth policy, campaign delivery, HSS, programme evaluation
22Bradley HershHealth policy, immunisation, outbreaks, campaigns, measles control
23Natasha HowardHealth policy, social epidemiology, immunisation service delivery, fragile setting, strong academic background
24Hector IzurietaImmunisation campaign management, public health, measles control, epidemiology, policy making
25Philippe JaillardVaccine delivery, cold chain equipment management, injection safety and waste management, logistics training program development
26Miloud KaddarHealth economics, economics of vaccines and immunisation, health system development and financing
27Clifford KamaraHealth development, immunisation services, recovery programme, management and evaluation of health programmes
28Jean Rostand KamgaFinancial & budget analysis, management and governance, audits, financial investigations
29Toagoe KarzonProject funding, financial reporting and budget control, conducting audits
30Tcha Landry KaucleyCold Chain, vaccine logistics, EPI monitoring & evaluation, public health management
31Wassim KhroufFinancial & budget analysis, audits, project assessment
32Vladimir LazarevikHealthcare system transformation, health financing design, health policy development
33Stefano LazzariOutbreak, epidemic and emergency response, HSS, monitoring and evaluation, grant management
34Dafrossa LyimoImmunisation campaign management, public health, health systems management, health policies, disease control
35Kapil MaithalConceptualizing, managing, strategizing and execution of development of vaccines for global use, vaccine advocacy and preparedness
36Osman MansoorImmunisation programmes, epidemiology & monitoring, measles control, cold chain & logistics
37Viviana MangiaterraChild health, epidemiology, HSS, immunisation programmes
38Florian Marks Public health, vaccinology and policy making, outbreak responses, campaign evaluations
39Tawanda MarufuFragile settings, HSS, epidemiology, health policy, HPV, Typhoid, measles
40Mark MillerEpidemiology, vaccine research, public health, outbreak investigations, disease control
41Sandra Mounier-JackImmunisation programmes, health systems strengthening, HPV vaccine, measles elimination, health policy and health financing
42Kondwani MsamphaFinancial & budget analysis, HSS, global health and integrated service delivery
43Amani MustafaImmunisation, new vaccines, campaign management, cold chain and health system planning and monitoring
44Maryanne NeillHealth information systems, cold chain logistics, immunisation coverage estimation.
45Benjamin NkowaneVaccine preventable disease programmes, implementation of mass vaccination campaigns, technical support for field operations in security risk areas, epidemiology and reproductive/sexual health
46Peter NsubugaEpidemiology, measles control, cold chain, HSS
47Jean Marc OliveImmunisation programmes, emergency strategies & disaster relief, measles elimination
48Virgil OnamaProject design, M&E, results-based management, health financing & policy, fragile settings
49Michael ParkProgramme management and evaluation, primary care, health systems and public health
50Ian PettHealth care, cold chain, HSS, outbreak response, emergencies
51Arletty PinelHealth systems strengthening, maternal health
52Arthur ReingoldEpidemiology, measles control, vaccination delivery, strengthening health infrastructure
53Cheikh Mohamed Hafis SeckFinancial & budget analysis, financial management of donor-funded programs, audit, grant agreements
54Craig ShapiroManagement of immunisation programmes, policy development, public health, cold chain evaluation, HSS activities
55Mario StassenDesign of development strategies, risk based management and patient safety, immunisation supply chain logistics (cold chain), CMC (Bio) Pharmaceuticals
56Simon (Sam) SterninGlobal health generalist, HSS, disaster management, coverage and equity, CSOs
57Abdelmajid TiboutiFinancial & budget analysis, health economics, health financing strategies, monitoring and evaluation
58Asnakew TsegaPublic health, epidemiology, programme management, monitoring and evaluation
59Vivien Tsu Epidemiology, new public health interventions, women's reproductive health, HPV, JE
60Margaret WatkinsImmunisation campaign management, epidemiology, public health interventions, outbreaks, evaluations
61Karen WilkinsImmunisation campaign management, proposals development, monitoring and evaluation, DQ assessments
62Aregai WoldegebrielEpidemiology, SIA, MNCH, outbreaks, monitoring and evaluation
63Shamsa ZafarMNCH, Gender

Country portal

Applying for or receiving Gavi support? Visit our country portal.  

28%

Pneumonia and diarrhoea account for 28% of deaths in under-fives in Gavi-supported countries.

MCEE-WHO 2016

More facts...

close icon

modal window here